Trump administration authorizes use of ‘very effective’ convalescent plasma treatment for COVID-19

Published



President Trump announced Sunday that the Food and Drug Administration granted emergency use authorization for convalescent plasma, a treatment that health experts believe could treat COVID-19.

“Today’s action will dramatically expand access to this treatment,” Trump said during a news conference in the White House. “Based on the science and the data, the FDA has made the independent determination that the treatment is safe and very effective.”

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.